Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors
Clinical trial NCT02588170 · COMPLETED
Trial details
- NCT number
- NCT02588170
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-07
- Primary completion
- 2019-03-31
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.